What does Covaxin’s Phase 3 efficacy data really mean? All your concerns on Bharat Biotech’s corona vaccine explained

Vaccine manufacturer Bharat Biotech has recently reported the interim efficacy of its COVID-19 vaccine Covaxin at 81 per cent depending on the large scale human clinical trials conducted by the company.